Premedication with cyclooxygenase-2 inhibitor meloxicam reduced postoperative pain in patients after oral surgery

International Journal of Oral and Maxillofacial Surgery

Volumn 35, Issue 7, 2006, Pages 613-617

  Aoki, T ^a   Yamaguchi, H ^b   Naito, H ^c   Shiiki, K ^c   Izawa, K ^d   Ota, Y ^d   Sakamoto, H ^a   Kaneko, A ^d  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b Ryugasaki Saiseikai Hospital   (Japan)

^c Iwaki Kyoritsu Gen Hosp   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cyclooxygenase 2 (COX 2) inhibitor; local anaesthesia; meloxicam; oral surgery; postoperative pain

Indexed keywords

AMPIROXICAM; CYCLOOXYGENASE 2 INHIBITOR; LIDOCAINE; LOXOPROFEN; MELOXICAM; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG SELECTIVITY; DRUG UTILIZATION; FEMALE; HUMAN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MOLAR TOOTH; NAUSEA AND VOMITING; OPERATION DURATION; ORAL SURGERY; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOMNOLENCE; STATISTICAL ANALYSIS; TOOTH EXTRACTION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ANESTHESIA, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MOLAR, THIRD; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PHENYLPROPIONATES; PREMEDICATION; PROSPECTIVE STUDIES; THIAZINES; THIAZOLES; TOOTH EXTRACTION;

EID: 33745015595     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2006.01.026     Document Type: Article

References (26)

1. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., Lines C., Riddell R., Morton D., Lanas A., Konstam M.A., and Baron J.A. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352 (2005) 1092-1102
2. Bridgeman J.B., Gillgrass T.G., and Zacharias M. The absence of any pre-emptive analgesic effect for non-steroidial anti-inflammatory drugs. Br J Oral Maxillofac Surg 34 (1996) 428-431
3. Busch U., Heinzel G., and Narjes H. The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man. Eur J Clin Pharmacol 48 (1995) 269-272
4. Campbell W.I., Kendrick R.W., and Fee J.P.H. Balanced pre-emptive analgesia: does it work? A double-blind, controlled study in bilateral symmetrical oral surgery. Br J Anaesth 81 (1998) 727-730
5. Desjardins P.J., Shu V.S., Recker D.P., Verburg K.M., and Woolf C.J. A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. Anesthesiology 97 (2002) 565-573
6. Dirig D.M., Isakson P.C., and Yaksh T.L. Efect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 285 (1998) 1031-1038
7. Dolan S., and Nolan A.M. N-methyl D-aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase-2 inhibitors. Neuroreport 10 (1999) 449-452
8. Dray A. Inflammatory mediators of pain. Br J Anaesth 75 (1995) 125-131
9. Hay C., and de Belleroche J. Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal coed. Neuroreport 8 (1997) 1249-1251
10. Hla T., and Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89 (1992) 7384-7388
11. Jones S.C. Relative thromboembolic risks associated with COX-2 inhibitors. Ann Pharmacother 39 (2005) 1249-1259
12. Kawai S. Cyclooxygenase selectivity and the risk of the gastro-intestinal complication of various non-steroidal anti-inflammatory drugs: a clinical consideration. Inflamm Res 47 Suppl. 2 (1998) S102-S106
13. Kelly D.J., Ahmad M., and Brull S.J. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth 48 (2001) 1000-1010
14. Kelly D.J., Ahmad M., and Brull S.J. Preemptive analgesia II: recent advances and current trends. Can J Anaesth 48 (2001) 1091-1101
15. Khan A.A., Brahim J.S., Rowan J.S., and Dionne A.A. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. Clin Pharmacol Ther 72 (2002) 44-49
16. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 59 (1994) 9-43
17. Mukherjee D., Nissen S.E., and Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. J Am Med Assoc 22-29 (2001) 954-959
18. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., and Woolf C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
19. Shaya F.T., Blume S.W., Blanchette C.M., Weir M.R., and Mullins C.D. Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med 165 (2005) 181-186
20. Treede R.D., Meyer R.A., Raja S.N., and Campbell J.N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38 (1992) 397-421
21. Trummlitz G., Ryn J., and Warner T.D. The molecular and biological basis for COX-2 selectivity. In: Pairet M., and Ryn J. (Eds). COX-2 inhibitors (2004), Birkhäuser Verlag, Basel 41-65
22. Willingale H.L., Gardiner N.J., McLymont N., Giblett S., and Grubb B.D. Prostanoids synthesized by cycli-oxygenase isoformes in rat spinal cord and their contribution to the development of neuronal hypersensitivity. Br J Pharmacol 122 (1997) 1593-1604
23. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature 306 (1983) 686-688
24. Woolf C.J., and Chong M.S. Preemptive analgesia: treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 77 (1993) 362-379
25. Xie W.L., Chipman J.G., Robertson D.L., Erikson R.L., and Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88 (1991) 2692-2696
26. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386